📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62P394L mouse model of Paget's disease (2018)

First Author: Daroszewska A

Attributed to: Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1242/dmm.035576

PubMed Identifier: 30154079

Publication URI: http://europepmc.org/abstract/MED/30154079

Type: Journal Article/Review

Parent Publication: Disease Models & Mechanisms

Issue: 9

ISSN: 1754-8403